buspirone has been researched along with Metabolic Diseases in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, D | 1 |
| Pagire, HS | 1 |
| Pagire, SH | 1 |
| Bae, EJ | 1 |
| Dighe, M | 1 |
| Kim, M | 1 |
| Lee, KM | 1 |
| Jang, YK | 1 |
| Jaladi, AK | 1 |
| Jung, KY | 1 |
| Yoo, EK | 1 |
| Gim, HE | 1 |
| Lee, S | 1 |
| Choi, WI | 1 |
| Chi, YI | 1 |
| Song, JS | 1 |
| Bae, MA | 1 |
| Jeon, YH | 1 |
| Lee, GH | 1 |
| Liu, KH | 1 |
| Lee, T | 1 |
| Park, S | 1 |
| Jeon, JH | 1 |
| Lee, IK | 1 |
| Ahn, JH | 1 |
1 other study available for buspirone and Metabolic Diseases
| Article | Year |
|---|---|
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglyc | 2019 |